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Asparagine-linked glycosylation of polypeptides in
the lumen of the endoplasmic reticulum is catalyzed
by the hetero-oligomeric oligosaccharyltransferase
(OST). OST isoforms with different catalytic subunits
(STT3A versus STT3B) and distinct enzymatic prop-
erties are coexpressed in mammalian cells. Using
siRNA to achieve isoform-specific knockdowns, we
show that the OST isoforms cooperate and act
sequentially to mediate protein N-glycosylation.
The STT3A OST isoform is primarily responsible for
cotranslational glycosylation of the nascent polypep-
tide as it enters the lumen of the endoplasmic
reticulum. The STT3B isoform is required for efficient
cotranslational glycosylation of an acceptor site adja-
cent to the N-terminal signal sequence of a secreted
protein. Unlike STT3A, STT3B efficiently mediates
posttranslational glycosylation of a carboxyl-terminal
glycosylation site in anunfoldedprotein. Thesedistinct
and complementary roles for the OST isoforms allow
sequential scanning of polypeptides for acceptor sites
to insure the maximal efficiency of N-glycosylation.
INTRODUCTION
Glycosylation of asparagine residues is an essential protein
modification reaction that occurs upon most proteins that enter
the secretory pathway in eukaryotic cells. Asparagine-linked
oligosaccharides are transferred onto polypeptides in the lumen
of the rough endoplasmic reticulum (RER) by the oligosaccharyl-
transferase (OST) using a dolichol pyrophosphate-linked oligo-
saccharide (OS-PP-Dol) as the donor substrate. It has long
been recognized that the high mannose oligosaccharide
(GlcNAc2Man9Glc3) is cotranslationally transferred to the
nascent polypeptide as the consensus glycosylation site (se-
quon, N-X-T/S) enters the RER lumen (Rothman and Lodish,
1977; Chen et al., 1995) by passage through the protein translo-
cation channel (Sec61 complex). Acceptor sites become acces-
sible to the OST active site when there are 65–75 residues of
protein between the sequon and the peptidyl-transferase site272 Cell 136, 272–283, January 23, 2009 ª2009 Elsevier Inc.on the large ribosomal subunit (Whitley et al., 1996; Nilsson
et al., 2003; Deprez et al., 2005). This polypeptide length includes
30 residues within the large ribosomal subunit plus roughly 25
residues of extended polypeptide required to span the distance
between the cytoplasmic and lumenal faces of the Sec61
complex. The reduced frequency of oligosaccharide addition
to glycosylation sequons located less than 75 residues from
the C terminus (Gavel and Von Heijne, 1990; Ben-Dor et al.,
2004) is thought to be explained by a more rapid passage of
the sequon past the OST active site following chain termination,
hence, if glycosylated these sites might be modified after the
entire protein has been translocated into the ER lumen. With
the noteworthy exception of human blood coagulation factor
VII (Bolt et al., 2005), posttranslational glycosylation reactions
have only been reported in mammalian cells under perturbed
conditions when OS-PP-Dol assembly was impaired (Duvet
et al., 2002) or when C-terminally truncated substrates were
analyzed (Kolhekar et al., 1998). Factor VII is particularly inter-
esting because one sequon is modified cotranslationally, while
a second sequon is modified posttranslationally (Bolt et al.,
2005).
Mammalian OST is an oligomeric membrane protein consist-
ing of seven to eight nonidentical subunits (reviewed in Kelleher
and Gilmore, 2006). Antibodies specific for the cytoplasmic
domain of ribophorin I, one of the first identified subunits of the
mammalian OST (Kelleher et al., 1992), inhibit protein transloca-
tion in vitro by blocking ribosome nascent chain (RNC) targeting
to the translocon (Yu et al., 1990). Furthermore, the OST and the
Sec61 complex cosediment with RNCs when the RER is solubi-
lized by a nonionic detergent as part of the ribosome-associated
membrane protein (RAMP) fraction (Go¨rlich et al., 1992; Shiba-
tani et al., 2005). Although the precise stoichiometry between
the OST and the Sec61 complex in uncertain, these studies
have led to the concept that a single OST is adjacent to each
active translocation channel, thereby facilitating cotranslational
N-glycosylation.
STT3 proteins are the active site subunits of the eukaryotic
OST (Yan and Lennarz, 2002; Nilsson et al., 2003). Vertebrate,
insect and plant genomes encode two STT3 proteins (STT3A
and STT3B) (Kelleher et al., 2003; Koiwa et al., 2003; Kelleher
and Gilmore, 2006) that are assembled into OST isoforms that
differ with respect to the in vitro specific activity and stringency
of selecting Dol-PP-GlcNAc2Man9Glc3 in preference to
OS-PP-Dol assembly intermediates that lack the terminal
glucose residue (Kelleher et al., 2003). STT3A and STT3B
mRNAs are widely expressed in human tissues, and both cata-
lytic subunits are coexpressed in tissue culture cell lines.
What advantage is provided to the cell by coexpression of the
more active, less selective, STT3B isoform together with the less
active, more selective, STT3A isoform? We have tested whether
the twoOST isoforms have redundant or distinct roles in N-linked
glycosylation by siRNA-mediated depletion of STT3A or STT3B.
We have found that full glycosylation of polypeptides involves
the cooperation of both OST isoforms. Detailed analysis of three
glycoprotein substrates revealed that glycosylation is sequential
and occurs by a more complex mechanism than previously
known. The STT3A isoform is primarily responsible for cotransla-
tional modification of sequons as the nascent polypeptide enters
the lumen of the RER. Depletion of STT3A, but not STT3B,
causes an induction of the unfolded protein response (UPR)
pathway. The STT3B isoform of the OST is less competent for
cotranslational glycosylation, but has the capacity to mediate
posttranslational modification of skipped glycosylation sites in
unfolded proteins.
RESULTS
Isoform-Specific Knockdowns of the OST
Small interfering RNA duplexes (siRNA) were designed to
mediate isoform-specific knockdowns of the OST complex.
The OST subunit ribophorin I is very stable in HeLa cells (t1/2 =
25 hr; Tsao et al., 1992), hence we anticipated that 3 days of
siRNA treatment would be required to achieve significant reduc-
tions in STT3A, STT3B, or ribophorin I expression. HeLa cell
extracts prepared 72 hr after siRNA transfection were analyzed
by protein immunoblotting (Figure 1). The STT3A siRNA reduced
STT3A expression to near background levels (<10% of control)
without reducing STT3B expression. The previous observation
that siRNAs designed to knockdown STT3A cause depletion of
STT3B (Wilson and High, 2007; Wilson et al., 2008) is likely
explained by an off-target effect. Interestingly, siRNAs specific
for STT3A caused an increase in STT3B levels, yet reduced
expression of ribophorin I (Figure 1, see quantification). A 7-fold
reduction in STT3B expression caused by STT3B siRNA was
accompanied by a slight increase in STT3A expression and
a decrease in ribophorin I levels.
The compensatory increases in catalytic subunit expression
level are likely explained by elimination of competition between
STT3A and STT3B for assembly with the shared set of noncata-
lytic OST subunits. Since the mammalian OST can be destabi-
lized by loss of the DAD1 subunit (Sanjay et al., 1998), we
suspected that STT3A or STT3B depletion destabilizes ribo-
phorin I. Consistent with this explanation, depletion of STT3A
plus STT3B led to a 2-fold reduction in ribophorin I content.
Furthermore, treatment of cells with siRNA specific for ribophorin I
caused a 2- to 3-fold reduction of both STT3A and STT3B
(Figure 1). Differences in the extent or duration of ribophorin I
depletion might explain why Wilson and colleagues do not
observe reductions in STT3A and STT3B content in cells treated
with siRNA for ribophorin I (Wilson et al., 2008).Many glycoproteins are unable to fold when glycosylation is
inhibited. The accumulation of defective proteins induces the
unfolded protein response (UPR) pathway to cope with the ER
protein folding stress (as reviewed by Schroder and Kaufman,
2006). Protein blots were probed with antibodies to BiP, an ER
chaperone that is upregulated by the UPR pathway (Figure 1).
Elevated levels of BiP were observed whenever STT3A levels
were reduced, either directly by transfection with STT3A siRNA
or indirectly by transfection with ribophorin I siRNA. The simulta-
neous depletion of STT3A plus STT3B caused the greatest
extent ofBiP induction.Depletion of STT3A, STT3Bor ribophorin I
did not reduce expression of the translocon protein Sec61a.
Digitonin-high salt extracts were assayed for OST activity to
correlate subunit loss with enzyme activity. Depletion of ribo-
phorin I, or depletion of STT3A plus STT3B caused a 3- to
4-fold reduction in OST activity (Figure 2A). Isoform-specific
depletions had less effect upon OST activity, in part due to the
Figure 1. Effects of siRNA-Mediated Knockdowns on STT3A,
STT3B, Ribophorin I, Sec61a, and BiP Expression
Digitonin-high salt extracts prepared from cells 72 hr after siRNA transfection
were processed for immunoblots using antisera for STT3A, STT3B, ribophorin I
(R I), BiP, Sec61a, and the a-subunit of the F1F0-ATPase. Asterisks designate
nonspecific bands. Similar results were obtained using a second set of each of
the siRNAs. The negative control siRNA is abbreviated NC.Cell 136, 272–283, January 23, 2009 ª2009 Elsevier Inc. 273
compensatory increase in expression of the other catalytic
subunit.
A co-immunoprecipitation approach was used to determine
the STT3A:STT3B ratio in HeLa cells. Antisera raised against
the N-terminus of STT3B quantitatively precipitated STT3B
from digitonin-high salt extracts under nondenaturing condi-
Figure 2. OST Activity and OST Complexes in siRNA-Treated Cells
(A) Digitonin-high salt extracts analyzed in Figure 1 were assayed for OST
activity. The values shown are averages of duplicate assays normalized to
DNA content and expressed relative to negative control siRNA-treated cells.
(B) Native immunoprecipitation using anti-STT3B. Aliquots of the detergent
extract (T), immunoprecipitate (P) and supernatant (S) fractions were analyzed
on immunoblots. STT3B, R I, glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) and IgG heavy chain (HC) are labeled.
(C) The relative amount of OST complexes in siRNA-treated cells was esti-
mated using protein immunoblot data (Figure 1) and the STT3A:STT3B ratio
(60:40) determined in panel (B).274 Cell 136, 272–283, January 23, 2009 ª2009 Elsevier Inc.tions, along with 40 ± 5% of the ribophorin I (Figure 2B). Only
traces of ribophorin I were immunoprecipitated when extracts
were prepared from STT3B-depleted cells. As unassembled
ribophorin I is not detected in cells or tissues (Kelleher and Gil-
more, 1997), we can conclude that the STT3A:STT3B ratio in
HeLa cells is roughly 60:40. The relative number of total OST
complexes (STT3A+STT3B) in the siRNA-treated cells was esti-
mated from the protein immunoblot data in Figure 1 and the
60:40 isoform ratio (Figure 2C). The in vitro OST activity
(Figure 2A) is not directly proportional to the calculated cellular
content of OST complexes (Figure 2C) due to the higher
in vitro activity of the STT3B isoform (Kelleher et al., 2003).
We next asked whether both isoforms of the OST are compo-
nents of the RAMP fraction. Proteomic analysis has shown that
the major components of canine pancreas high-salt RAMP frac-
tion are the Sec61, TRAM and TRAP complexes plus the signal
peptidase and the STT3A isoform of the OST (Shibatani et al.,
2005). Here, we observed that the STT3B isoform of the OST
was more readily extracted than the STT3A isoform from
a HeLa cell RAMP fraction under low salt conditions (Figure S1
available with this article online).
Hypoglycosylation of Endogenous Glycoproteins
The effect of OST isoform depletion on total N-linked glycopro-
tein synthesis was evaluated by capturing pulse-labeled
glycoproteins with ConA Sepharose beads. Total radiolabeled
glycoproteins were reduced by less than 5% in cells treated
with either STT3 siRNA. SDS-PAGE resolution of the ConA
eluate revealed several glycoproteins, including p65, that were
less intense in extracts from STT3A-depleted cells (Figure 3A,
circles) compared to control or STT3B-depleted cells. The
reduced intensity of p65 was accompanied by the appearance
of three more rapidly migrating proteins that are likely hypogly-
cosylated p65 variants (Figure 3A, triangle). Endoglycosidase H
digestion (Figure S2A), and alkaline fractionation of total cell
homogenates prior to ConA binding (Figure S2B) revealed that
p65 is a soluble protein with five N-linked glycans. Candidates
for p65 were identified using a bioinformatics approach and
tested by immunoprecipitation of pulse-labeled cell extracts.
Antisera specific for the lysosomal protein saposin D immuno-
precipitated p65 (Figure S2C). Saposins A–D are derived by
proteolytic processing of prosaposin (Figure 3B), a 65 kD
precursor that is comprised of alternating spacer segments
and saposin domains (as reviewed by Kishimoto et al., 1992).
Prosaposin is also secreted by many cell types (Kishimoto
et al., 1992).
Processing of prosaposin (pSAP-65) in control cells was
analyzed by pulse-chase labeling. The gel-mobility of pSAP-65
increased in a stepwise manner at the 10 and 30 min chase
points (Figure 3C) due to sequential trimming of glucose and
mannose residues (Figure S3A). As reported previously (Rijn-
boutt et al., 1991) transport of pSAP-65 from the ER to the Golgi
is rapid. The half time for appearance of prosaposin bearing
complex oligosaccharides (pSAP-75) was 33 min. Intact pSAP-
75 was first detected in cell culture media at the 30 min chase
point, and was as abundant as intracellular prosaposin after
a 1 hr chase.
Figure 3. Hypoglycosylation of Prosaposin in STT3A-Depleted Cells
(A, C, and D) HeLa cells treated with the indicated siRNAs were pulse-labeled for 2 min (D) or 5 min (A and C) and chased as indicated (C and D).
(A) One plate of control cells was treated with tunicamycin (Tm) prior to labeling. Equal amounts of 35S-labeled protein were incubated with Con A beads. Glyco-
proteins were eluted and resolved by SDS-PAGE. Circles designate glycoproteins that decrease in intensity in STT3A-depleted cells. The triangle designates
hypoglycosylated variants of p65.
(B) Diagram of preprosaposin showing the signal sequence (black), the homologous N- and C-terminal domains (NT and CT; cyan), the saposin domains (yellow),
and spacer segments (green). Glycosylation sites (e.g., 80 NAT) disulfide bonds (red lines) and lysosomal processing sites (arrowheads) are shown. The disulfide-
bonding pattern of the invariant cysteine residues in the NT and CT domains is not known.
(C) Pulse-chase labeling of prosaposin in control cells. Intracellular (cells) and secreted (media) prosaposin was recovered by immunoprecipitation. The ER
(pSAP-65) and Golgi (pSAP-75) forms of prosaposin are labeled. The arrowhead designates a nonspecific band. (D) Pulse-chase labeling of prosaposin. Glyco-
forms of pSAP-65 are labeled; fully glycosylated pSAP-75 is indicated by the bracket. The average number of glycans per pSAP-65 was calculated after quan-
tification of the pSAP-65 glycoforms.Prosaposin was cotranslationally glycosylated by control
cells or STT3B-depleted cells (Figure 3D). The short duration
of the pulse (2 min) monitors cotranslational glycosylation
since prosaposin synthesis takes roughly 90 s (527 residues at
6 residues/sec, (Hershey, 1991)). Prosaposin glycoforms
lacking up to four oligosaccharides were synthesized by
STT3A-depleted cells, with an average reduction of 1.5 glycans
per chain. Notably, the 2-fold decrease in total OST content in
these cells did not cause a bimodal distribution of pSAP-65
glycoforms (i.e., 0 or 5 glycans). The average number of
glycans on pSAP-65 did not increase during the chase incuba-
tion, indicating that skipped sites are not posttranslationally
glycosylated. Instead, hypoglycosylated variants of pSAP-65
were trimmed, as shown by the increased gel mobility of
each glycoform at the 10 and 30 min chase points. Overlap
between hypoglycosylated pSAP-75 and pSAP-65 caused the
diffuse smear detected at the 60 min chase point. Experiments
conducted using ConA to isolate high-mannose glycoproteins
yielded identical results concerning processing of pSAP-65
(Figure S3B).Cotranslational Glycosylation of a Sequon Near
the Signal Peptidase Cleavage Site
Procathepsin C (pCatC) is a major secreted HeLa cell glycopro-
tein (Vollenweider et al., 1998) that has four glycans (Figure 4A).
Procathepsin C chains lacking 1-4 N-linked glycans were
synthesized by cells that were treated with siRNA for ribophorin I
or siRNAs for STT3A plus STT3B (Figure 4B). The 4-fold reduc-
tion in OST content and activity in these siRNA-treated cells
did not result in significant synthesis of nonglycosylated pCatC,
but instead reduced the average number of glycans per protein
by 25% or less. A 2 min pulse, followed by an 8 min chase,
showed that pCatC glycosylation was cotranslational even
though the cellular concentration of the OSTwas reduced 4-fold.
Depletion of STT3B resulted in the synthesis of pCatC chains
lacking 0–2 glycans (Figure 4C). Roughly half the pCatC chains
lack one glycan, suggesting that one sequon is typically modified
by STT3B. Skipped sites in pCatC were not modified during
a 1 hr chase in STT3B-depleted cells. Procathepsin Cwas immu-
noprecipitated from STT3A-depleted cells that were pulse-
labeled for 2 min and chased for 8 min (Figure 4D). Even whenCell 136, 272–283, January 23, 2009 ª2009 Elsevier Inc. 275
Figure 4. Glycosylation of pCatC in siRNA-Treated Cells
(A) Diagram of the preprocathepsin C showing the signal sequence (black), retained propeptide (cyan), cleaved propeptide, (white), heavy chain (magenta) and
light chain (yellow). Glycosylation sites, disulfide bonds (red lines) and free cysteines (red dots) are shown.
(B–D) Cells treated with the indicated siRNAs prior to pulse-chase labeling were used for pCatC immunoprecipitation. Results obtained with two siRNAs for
ribophorin I are shown.
(E) Diagrams of pCatC-HA glycosylation site mutants. Cells cotransfected with pCatC-HA constructs and negative control () or STT3B (+) siRNAs were pulse
labeled for 3 min, and immunoprecipitated using anti-HA. (B, D, and E) As indicated, samples from control cells were digested with Endo H (EH). Procathepsin C
with 0-4 N-linked glycans were resolved by SDS-PAGE and the average number of glycans per pCatC chain was calculated.the pulse-labeling period was similar to the biosynthesis time
(80 s), pCatC had an average of 3.9 glycans in controls cells
and 3.8 glycans in STT3A-depleted cells. Taken together, these
results indicate that three of the four glycosylation sites in pCatC
can be cotranslationally modified by either STT3A or STT3B,
while a fourth site is poorly glycosylated in STT3B-depleted cells.
The N-terminal sequon in pCatC is four residues from the
signal sequence cleavage site (Figure 4A). Cysteine residues
within the N29 and N53 sequons form disulfides with cysteines
flanking the third sequon (Horn et al., 2002). We tested the
hypothesis that N29 is hypoglycosylated in STT3B-depleted
cells by expressing HA-tagged derivatives of pCatC
(Figure 4E). As observed for endogenous pCatC, depletion of
STT3B caused hypoglycosylation of one site in pCatC-HA.
Mutagenesis of the N-terminal sequon (N29Q pCatC-HA) elimi-276 Cell 136, 272–283, January 23, 2009 ª2009 Elsevier Inc.nated hypoglycosylation of pCatC in STT3B-depleted cells rela-
tive to control cells. Remarkably, pCatC chains that retain the
N29 sequon as the only acceptor site were hypoglycosylated
in STT3B-depleted cells. Proximity to the signal sequence
cleavage site, rather than cysteine within the sequon, is the
most likely explanation for the STT3B-dependent modification
of the N29 sequon in pCatC.
The STT3B Isoform Mediates Posttranslational
N-Glycosylation
Blood coagulation factor VII has two sequons (Figure 5A), one
of which (N183) is glycosylated cotranslationally, while the
second site (N360) is mainly glycosylated posttranslationally
(Bolt et al., 2005). Factor VII pulse-labeled for 45 s consisted of
nascent chains (g-nc and nc) plus nonglycosylated (FVII-0),
Figure 5. Glycosylation of FVII in siRNA-Treated Cells
(A) Diagram of the FVII precursor showing the signal sequence (black), the gamma-carboxyglutamate domain (green), two EGF-like domains (cyan), the activation
peptide (purple) and the catalytic domain (red). Glycosylation sites and disulfide bonds are shown. Cells cotransfected with wild-type (B–F), N360Q (G), or N183Q
(H) FVII plasmids and negative control (B, D, G, and H), STT3A (C, E, G, and H), or STT3B (F–H) siRNAs were pulse labeled for 45 s (B and C) or 2 min (D–H) and
chased as indicated. One pulse labeled sample was digested with Endo H (EH). Full-length FVII polypeptides that contain 0, 1, or 2 N-linked oligosaccharides
were resolved from glycosylated nascent chains (g-nc) and nonglycosylated and deglycosylated nascent chains (nc). (D–F) The percentages of FVII molecules
that have 0 (triangles), 1 (circles) or 2 (squares) N-linked oligosaccharides are shown.mono-glycosylated (FVII-1) and di-glycosylated (FVII-2) full-
length factor VII (Figure 5B). Endo H digestion of the 45 s
pulse-labeled sample showed that most nascent chains carry
a single glycan which, based upon nascent chain length, is linked
to N183. Posttranslational glycosylation of FVII at the N360 site
occurred during the chase incubation. The kinetics of FVII glyco-
sylation was analyzed using a more extensive pulse-chase
experiment. The time courses for disappearance of FVII-0 and
formation of FVII-2 in control cells are well fit by single exponen-
tial equations (Figure 5D), with t1/2 values of 8 and 9 min respec-
tively (Table S1). Disappearance of FVII-1 is well fit by a double
exponential equation consisting of the parameters that describe
consumption of FVII-0 and formation of FVII-2. Pulse-chase
labeling of the N360Q Factor VII mutant revealed that 20% of
the N183 sites are not cotranslationally glycosylated, and thatthe majority of skipped N183 sites are not modified during the
chase (Figure 5G). Consistent with the detection of FVII-2 at
the 0 min chase point in control cells (Figure 5D), roughly one
third of the N360 sites were glycosylated at the 0min chase point
in the N183Q FVII mutant (Figure 5H).
The siRNA-treated cells were transfected with a factor VII
expression vector to determine whether a specific OST isoform
mediates glycosylation of N183 and N360. Depletion of STT3A
increased the percentage of FVII-0 that was detected after pulse
labeling for 45 s (Figure 5C) or 2min (Figure 5E). Nonglycosylated
(i.e., Endo H resistant) nascent chains were readily detected in
the 45 s pulse-labeled sample. Consumption of FVII-0 and
formation of FVII-2 occurred with kinetics that were comparable
to that observed for control cells (t1/2 = 6.6 and 8.4 min respec-
tively, Table S1). The plateau value for FVII-1 is elevated relativeCell 136, 272–283, January 23, 2009 ª2009 Elsevier Inc. 277
to control cells (Figure 5E) primarily due to reduced
cotranslational glycosylation of the N183 site (Figure 5G). These
data indicate that STT3A isoform is important, but not essential,
for cotranslational N-glycosylation of Factor VII. The STT3A iso-
form is completely dispensable for posttranslational glycosyla-
tion of N360 (Figure 5H).
Posttranslational glycosylation was greatly reduced in the
STT3B-depleted cells, as indicated by the low extent and slow
kinetics (t1/2 36 min) of FVII-2 formation (Figure 5F). Inefficient
posttranslational modification of the N360 sequon in STT3B-
depleted cells was confirmed by pulse-chase analysis of the
N183Q mutant (Figure 5H). STT3B depletion did not reduce
cotranslational modification of N183, as shown by the low
percentage of FVII-0 synthesized during the 2 min pulse label
(Figure 5F) and the efficient glycosylation of the N360Q factor
VII mutant (Figure 5G). The STT3B isoform is responsible for
posttranslational glycosylation of FVII on N360 (Figure 5H) but
dispensable for cotranslational glycosylation of FVII on N183
(Figure 5G).
In control and STT3A-depleted cells, posttranslational glyco-
sylation of wild-type factor VII at N360 to yield FVII-2 is more effi-
cient than expected from the analysis of the single site mutants
(N183Q and N360Q). If glycosylation of the two sequons is inde-
pendent, the probability of FVII-2 formation is the product of the
single site modification values (0.7 3 0.8 in control cells).
Enhanced formation of FVII-2 (e.g., 0.73 instead of 0.56) indi-
cates that posttranslational glycosylation of N360 by the
STT3B isoform is positively regulated by cotranslational glyco-
sylation of N183.
Protein Folding Limits Posttranslational Glycosylation
by STT3B
Why can certain sequons be modified minutes after protein
termination while skipped sites in pSAP-65 are refractory to
posttranslational glycosylation? A hydrogen bond between the
side chain of serine or threonine and the carboxamide oxygen
of asparagine is proposed to be essential for catalysis by the
OST (Imperiali et al., 1992), and this conformation cannot be
achieved upon folding of the saposin domain. Saposin domains
have a conserved N-glycosylation site (N80 in saposin A) located
in a turn joining two a-helical segments (Ahn et al., 2006) and are
stabilized by a hydrophobic protein core and three invariant
disulfide bonds (Figure 6D). To obtain evidence concerning the
rate of folding of pSAP-65 and factor VII, we treated detergent
lysates of pulse-labeled control cells with the cysteine modifica-
tion reagent PEG-maleimide. As a control, we examined pegyla-
tion of pCatC, a protein with five disulfide bonds and three free
cysteine residues (Figure 4A). Only one cysteine (C355) in pCatC
is accessible to a bulky reagent like PEG-maleimide in the folded
state (Turk et al., 2001; Horn et al., 2002). Pegylation of pulse-
labeled pCatC yields a ladder (Figure 6A) as observed previously
for other proteins (Lu and Deutsch, 2001), where each PEG
adduct increases the apparent molecular weight of pCatC by
10-15 kD. Reduced levels of pCatC with three PEG-Mal adducts
at the 30 min chase point suggests that some chains have
folded, and have a single exposed cysteine residue.
Due to the high number of cysteine residues in pSAP-65
(Figure 3B), we focused our analysis on the presence of PEG-278 Cell 136, 272–283, January 23, 2009 ª2009 Elsevier Inc.Mal resistant pSAP-65 and pSAP-75 (Figure 6B). More than
50% of pSAP-65 chains were PEG-Mal insensitive after the
pulse, indicating that pSAP-65 disulfides form rapidly. Although
PEG-Mal adducts of pSAP-65 were detected at the 0 and 8 min
chase points, these adducts disappeared by the 30 min chase
point, and pegylated derivatives of pSAP-75 were not detected.
Formation of disulfide bonds in factor VII was evaluated by
comparing the labeling intensity of FVII-0, FVII-1 and FVII-2 in
the absence or presence of PEG-Mal (Figure 6C). In contrast to
prosaposin, Factor VII was completely susceptible to pegylation
after the pulse. Nonglycosylated FVII-0 and monoglycosylated
FVII-1 remained sensitive to pegylation for 30 min. Acquisition
of PEG-Mal resistance by FVII-2 lagged well behind addition of
the second glycan. These results are consistent with the
previous conclusion that N360 glycosylation occurs prior to
folding of factor VII (Bolt et al., 2005).
DISCUSSION
The objective of this study was to elucidate the in vivo role of the
two OST isoforms during protein glycosylation in mammalian
cells. Analysis of glycoprotein synthesis in OST isoform-depleted
cells revealed that the OST isoforms cooperate in a sequential
manner to glycosylate the full range of acceptor sites in
glycoproteins.
Nascent Glycoproteins Contact Multiple OSTs
If a single OST complex is adjacent to each active translocation
channel, a 40% reduction in OST content in the STT3A-depleted
cells should yield translocons that lack an OST complex, thereby
resulting in the synthesis of a mixture of fully glycosylated and
nonglycosylated proteins. Contrary to this prediction, total
glycoprotein synthesis was reduced by less than 5% when
STT3A was depleted. Even a 4-fold reduction in OST content
in the double-knockdown cells (STT3A + STT3B) led to the
synthesis of a heterogeneous mixture of pCatC glycoforms.
Remarkably, nonglycosylated pCatC chains were barely detect-
able. Models that specify localization of a single OST adjacent to
each protein translocation channel are incompatible with the
observed heterogeneity of hypoglycosylated glycoproteins.
Instead, we can conclude that the OST is present in excess rela-
tive to active translocons (Figure 7A), and that nascent polypep-
tides contact multiple OST complexes upon emergence into the
ER lumen (Figure 7B). Similar patterns of protein hypoglycosyla-
tion were also observed in yeast cells when synthesis of Stt3p
was placed under control of the GAL1/GAL10 promoter and
STT3 transcription was repressed by growing cells in glucose
containing media (Zufferey et al., 1995). An excess of the OST
relative to active translocation channels is therefore a conserved
property of the endoplasmic reticulum. Quantitative protein
immunoblots indicate that canine pancreas microsomes have
an excess of OST complexes relative to active protein transloca-
tion channels (Guth et al., 2004).
Sequential Roles for OST Isoforms in N-Glycosylation
Analysis of single knockdowns revealed that certain glycopro-
teins like ribophorin I (Figure 1) were not hypoglycosylated.
Glycosylation sites that can be efficiently modified by both
Figure 6. Disulfide Bond Formation in FVII, pCatC, and pSAP
(A–C) Control cells were pulsed for 5 min and chased as indicated. Cell extracts were treated with PEG-maleimide (PEG-Mal) as indicated prior to immnuopre-
cipitation of pCatC (A), pSAP (B), or FVII (C). Proteins are labeled as in Figure 3–5. Brackets labeled 1–4 designate the migration position of proteins that have 1–4
PEG-Mal adducts. Larger adducts (data not shown) migrated as a smear. The percentage of PEG-Mal resistant pCatC, FVII-1, FVII-2, and pSAP-65 relative to the
untreated sample is shown below each panel. (D) The saposin domain is stabilized by three disulfide bonds (in red) and a hydrophobic core (A, I, L,V, and M
residues are gray). The distance between the carboxamide oxygen of N80 and the side chain of T82 is 10.9 A˚. N101 and T103 are on opposite faces of the third
a-helix. The figure was created with MacPyMOL software using the saposin A structure (PDB 2DOB).OST isoforms appear to be common based upon a comparison
of total pulse-labeled glycoproteins isolated with ConA beads.
However, pulse-chase experiments demonstrated that deple-
tion of STT3A or STT3B had nonequivalent effects upon cotrans-
lational modification of pCatC and pSAP-65. Radiolabeled NYT
is used as the acceptor substrate in the in vitro OST assay, so
it was formally possible that the more active STT3B isoform
prefers NXT sites while the less active STT3A complex prefers
NXS sites. This explanation for substrate specificity can be dis-
counted because the STT3A isoform efficiently glycosylates
NXT and NXS sites in prosaposin, while the STT3B enzyme
glycosylates NXT and NXS sites in pCatC.
Nonidentical phenotypes for STT3 mutants have also been
observed in Arabidopsis thaliana. A T-DNA insertion into the
A. thaliana STT3A gene, but not theSTT3B gene, causes osmotic
sensitivity of root tips, and induction of the UPR pathway due to
protein hypoglycosylation (Koiwa et al., 2003). In contrast to the
viable single mutants, the double mutant (stt3a-1 stt3b-1) is
gametophytic lethal, indicating that the plant STT3 proteins
have partially overlapping roles.
In vivo pulse-labeling of nascent glycoproteins was essential
to allow resolution of cotranslational and early posttranslational
glycosylation events. The N183 site in factor VII is an obligatory
cotranslational glycosylation site, while the N360 site in primarily
posttranslational. Depletion of STT3A reduced the efficiency of
N183 glycosylation without altering the kinetics of N360 glyco-
sylation. In contrast, STT3B depletion did not impact N183
glycosylation but reduced the rate and extent of posttransla-
tional glycosylation of N360. Taken together, these results
indicate that the in vivo substrate specificity is explained by
sequential scanning of the nascent polypeptide for sequons by
the STT3A and STT3B isoforms.
What additional evidence supports the conclusion that the
STT3A isoform is primarily responsible for cotranslational glyco-
sylation? Depletion of STT3A caused a dramatic decrease in
cotranslational glycosylation of pSAP-65. Induction of the UPR
pathway upon depletion of STT3A but not STT3B, supports the
conclusion that most glycans are added by the STT3A isoform.
Efficient cotranslational modification of sequons is explained
by localization of the OST adjacent to the translocon, such thatCell 136, 272–283, January 23, 2009 ª2009 Elsevier Inc. 279
roughly 20 residues of nascent polypeptide span the distance
between the lumenal face of the Sec61 complex and the OST
active site. Experiments using an appropriately positioned
cryptic glycosylation site adjacent to a photoreactive lysine
derivative allowed efficient crosslinking of a nascent polypeptide
to STT3A (Nilsson et al., 2003). A crosslinked product that might
correspond to STT3B was conspicuously absent, consistent
with a more distal location for STT3B relative to the translocon
(Figure 7A).
Accurate donor substrate selection is important for glycopro-
tein quality control in the ER because the glycan trimming
intermediate Glc1Man9GlcNAc2 is recognized by the lectin chap-
erones calnexin and calreticulin (as reviewed by Helenius and
Aebi, 2004). Exquisite selection of Glc3Man9GlcNAc2-PP-Dol in
preference to lumenally oriented OS-PP-Dol assembly interme-
diates is a property of the STT3A isoform (Kelleher et al.,
2003). Cotranslational glycosylation of proteins by the STT3A
isoform insures that the transferred glycans have the correct
structure for the ER quality control pathway.
Since depletion of STT3A did not eliminate cotranslational
glycosylation, we can conclude that the STT3B isoform has
cotranslational access to skipped glycosylation sites
(Figure 7B), thereby enhancing the fidelity of N-glycan addition.
Because the STT3B isoform is less proximal to the Sec61
complex, the efficiency of cotranslational glycosylation is
impaired when STT3A is depleted (Figure 7E). Cotranslational
access of both OST isoforms to substrates explains why many
HeLa cell glycoproteins were not hypoglycosylated in STT3A-
depleted cells (Figure 3A). The higher turnover rate of the
STT3B isoform would favor cotranslational and posttranslational
modification of skipped glycosylation sites prior to protein
folding.
STT3B-Specific Glycosylation Sites
Two of the three substrates we tested were hypoglycosylated in
STT3B-depleted cells. The N360 sequon in factor VII is 84 resi-
dues from the C terminus, so chain termination will occur soon
after this sequon becomes accessible to the OST. Hence, ineffi-
cient cotranslational glycosylation of N360 is not surprising. We
predict that sequons located less than 75 residues from the
C terminus of a protein constitute a major class of STT3B
substrates (Figure 7F).
Hypoglycosylation of procathepsin C in STT3B-depleted cells
revealed that STT3B sites are not restricted to the extreme
C terminus of the protein, nor are STT3B sites obligatorily post-
translational. Disulfide bond formation and N-glycosylation are
competing reactions (Allen et al., 1995; Tanaka et al., 2002),
hence the N29 site in pCatCmust be glycosylated prior to forma-
tion of the C30-C118 disulfide. Sequons near the signal
sequence cleavage sites of yeast prepro-a-factor and invertase
are poorly glycosylated when signal sequence cleavage is
blocked (Chen et al., 2001). In the case of pCatC, the proximity
between the signal sequence cleavage site and the N29 sequon
likely prevents access to the OST active site prior to signal
sequence cleavage (Figure 7C). Sequons in lumenal segments
of integral membrane proteins are not glycosylated if the aspar-
agine residue is less than 30-40A˚ from the membrane surface
(Nilsson and von Heijne, 1993). Upon cotranslational cleavage
of the signal sequence, the N29 site in pCatC may exit the
lumenal face of the translocon too rapidly to be modified by
Figure 7. Cooperation between OST Isoforms in N-Linked Glycosylation
Cotranslational glycosylation of nascent glycoproteins in mammalian cells (A and B). Skipped sites can be cotranslationally glycosylated by STT3B (B). The signal
sequence (wavy line) remains bound to the translocon until cleaved (C). Cotranslational glycosylation of an extreme N-terminal glycosylation site by the STT3B
isoform (D). Reduced efficiency of cotranslational glycosylation in STT3A-depleted cells (E). Posttranslational glycosylation of a C-terminal sequon by the STT3B
isoform (F) is limited by protein folding (G).280 Cell 136, 272–283, January 23, 2009 ª2009 Elsevier Inc.
the translocon proximal STT3A OST that is scanning the nascent
polypeptide for glycosylation sites, but be readily accessible to
the translocon distal STT3B isoform (Figure 7D).
Competition between Posttranslational Glycosylation
and Protein Folding
Posttranslational glycosylation of proteins by the STT3B isoform
of the OST appears to be limited by folding of the polypeptide in
the ER lumen (Figure 7F and 7G). As an example of a rapidly
folding protein, more than 50% of pSAP-65 chains lack acces-
sible cysteine residues at the end of a 5 min pulse-labeling
period. Rapid formation of disulfides in pSAP-65 is consistent
with the kinetics of glycan trimming, acquisition of complex
glycans, and secretion of pSAP-75. Point mutations (N215H or
T217I) in prosaposin that prevent glycosylation at N215 cause
a variant form of metachromatic leukodystrophy (Kretz et al.,
1990;Wrobe et al., 2000). Folding and transport of N215H prosa-
posin to the lysosome is normal, but glycan deficient saposin B is
less active (Wrobe et al., 2000). Skipped sites in pSAP-65 were
not substrates for posttranslational glycosylation (Figure 7G).
At the other extreme, posttranslational glycosylation of N360 in
FVII is permitted because hypoglycosylated FVII-1 remains
unfolded for more than 30 min after the protein enters the ER
lumen (Figure 7F).
Posttranslational glycosylation of sequons is not restricted to
the mammalian STT3B, but appears to be an ancient and
conserved property of the OST. The single subunit Campylo-
bacter jejuni OST (PglB) can glycosylate sequons on a folded
protein if the acceptor site is located in a flexible loop (Kowarik
et al., 2006). The variant surface glycoprotein (VSG221) of Trypa-
nosoma brucei has two glycosylation sites; one site is cotransla-
tionally glycosylated with aGlcNAc2Man5 glycan, while a second
site located near the extremeC terminus is modified posttransla-
tionally with a GlcNAc2Man9 glycan (Ferguson et al., 1986;
Manthri et al., 2008). The utilization of different OS-PP-Dol
donors for the cotranslational and posttranslational sites might
be explained by the presence of three STT3 genes in the T. bru-
cei genome (Manthri et al., 2008). Duplication of the STT3 gene
and subsequent divergence of STT3A and STT3B has allowed
the evolution of OST isoforms that are optimized for complemen-
tary roles in N-glycan addition. We propose that the STT3B
isoform of the OST acts after the initial stage of glycoprotein
synthesis to enhance sequon occupancy and maximize the effi-
ciency of chaperone-mediated glycoprotein folding and quality
control.
EXPERIMENTAL PROCEDURES
Cell Culture and Plasmid or dsRNA Transfection
Two dsRNAs for each target (STT3A, STT3B and R I) were custom synthesized
by Dharmacon. Sequences of dsRNAs are in the supplemental materials.
Negative control siRNA was purchased from QIAGEN.
HeLa cells (ATCC CCL-13) were cultured in 10 cm2 dishes at 37C in DMEM
(GIBCO), 10% fetal bovine serum with penicillin (100 units/ml) and strepto-
mycin (100 mg/ml). Approximately 2 3 105 HeLa cells were plated and grown
for 24 hr prior to transfection with 30 nM dsRNA and Lipofectamine 2000 in
OptiMEM using protocols from Dharmacon. Cells were typically assayed
72 hr after transfection. To achieve better depletion of STT3B for pulse-
labeling experiments, cells were subjected to a second siRNA transfectionafter 48–72 hr using 40–60 nM siRNA and were assayed 48 hr after the second
transfection.
Construction of factor VII and pCatC-HA glycosylation mutants is described
in the supplemental materials. Cells were transfected with the plasmid
pcDNA3-FVII, obtained from Dr. Katherine High (Children’s Hospital of Phila-
delphia), 48 hr after treatment with negative control or STT3A siRNAs and
were analyzed 24 hr later. After 48–72 hr of treatment of cells with STT3B
siRNA, cells were sequentially transfected with STT3B siRNA and pcDNA3-
FVII or pcDNA3-pCatC-HA and analyzed 48 hr later. For each plate, 6 mg of
plasmid DNA was transfected with Lipofectamine 2000 using the manufac-
turer’s instructions.
In Vitro Oligosaccharyltransferase Assay
Cells at 70% confluency were washed and then scrape-extracted using a digi-
tonin-high salt buffer as described (Kelleher and Gilmore, 1997). An aliquot of
the extract was removed to isolate DNA (FlexiGene DNA Kit, QIAGEN), which
was quantified (A260) to normalize OST activity relative to cell number. The
remainder of the extract was digested with DNase I (50 mg/ml, Sigma) prior
to clarification by centrifugation. Clarified extracts were assayed for OST
activity as described (Kelleher and Gilmore, 1997) using 10 mM of Na-Ac-
Asn-[125I]Tyr-Thr-NH2 and 0.6 mM porcine pancreas OS-PP-Dol (63%
Glc3Man9GlcNAc2-PP-Dol).
Antibodies and Native Immunoprecipitation
Sources of antibodies are listed in the supplemental materials. Clarified digi-
tonin extracts from control and STT3B-depleted cells were diluted in buffer
to obtain a final concentration of 50 mM Tris-Cl, 150 mM NaCl, 1% digitonin,
1mMMgCl2, 1mMMnCl2, 1mMDTT (native IP buffer). Digitonin samples were
incubated overnight with Protein A-Sepharose beads precoated with the
STT3B antibody. Immunoprecipitates were washed with native IP buffer
containing 0.1% digitonin and eluted with gel loading buffer.
Radiolabeling, Immunoprecipitation, and ConA Fractionation
of Glycoproteins
Cell culture medium was replaced with methionine and cysteine free DMEM
media (GIBCO), containing 10% dialyzed fetal bovine serum 20 min prior to
the addition of 200 mCi/ml of Tran35S label (MPBiomedical). The pulse-labeling
period was terminated by the addition of unlabeled methionine (3.75 mM) and
cysteine (0.75mM). Cells from one culture dish at each time point were lysed at
4C by a 30 min incubation with 1 ml of 50 mM Tris-HCl pH 7.4, 2% Triton
X-100, 500 mM NaCl, 5 mM MgCl2, 1X PIC, 200 mM PMSF, and 1 mM DTT.
Cell lysates were clarified by centrifugation (1 min at 30,000 rpm; TLA-100.4
rotor), diluted with 400 ml of 50 mM Tris-HCl, 1X PIC and precleared by incu-
bation for 1-2 hr with a mixture of Protein A and Protein G Sepharose beads
(Zymed Laboratories). The precleared lysates were incubated for 16 hr with
antibody prebound to a second aliquot of Protein A- and Protein G-Sepharose
beads. Beads were washed 7 times with 50 mM Tris-HCl, 500 mM NaCl, 1%
Triton X-100, 0.1% SDS, 3 mM EDTA and twice with 10 mM Tris-HCl, 150 mM
NaCl before eluting proteins with gel loading buffer. As indicated, immunopre-
cipitated proteins were digested with Endo H (New England Biolabs). Dry gels
were exposed to a phosphor screen (Molecular Dynamics) and scanned in
Molecular Imager FX (BioRad) for quantification.
Total radiolabeled glycoproteins were isolated using ConA Sepharose
beads. A dish of radiolabeled cells was lysed and proteins denatured at
55C in 1 ml of 50 mM Tris-HCl (pH 7.4), 0.5% SDS, 20 mM DTT, 1X PIC,
200 mM PMSF. The lysates were diluted 5-fold with 50 mM Tris-HCl, 1.25%
Triton X-100, 5 mM MgCl2, 1X PIC, 200 mM PMSF and digested for 15 min
at 4C with 50 mg/ml of DNase I. Extracts were supplemented with 150 mM
NaCl, 2 mMMnCl2, 2 mMCaCl2 and incubated with 150 ml of ConA Sepharose
4B (Sigma). The ConA beads were washed with 50 mM Tris-HCl, 0.1% SDS,
1% Triton X-100, 500 mM NaCl, 1 mM MgCl2, 1 mM MnCl2, 1 mM CaCl2
and glycoproteins were eluted during a 1 hr incubation at 37C with wash
buffer containing 1 M methyl a-D-mannopyranoside (Sigma). As a control,
cells were treated with tunicamycin (10 mg/ml) for 30 min before radiolabeling.Cell 136, 272–283, January 23, 2009 ª2009 Elsevier Inc. 281
Modification of Cysteine Residues with PEG-Maleimide
Cells were pulse-labeled and chased prior to lysis in a pH 7.1 phosphate buffer
(10 mMNaHPO4, 2 mM KH2PO4, 2.7 mMKCl, 500 mMNaCl, 2% Triton X-100,
1X PIC, 200 mM PMSF) with or without 5 mM PEG-maleimide 5K (Sigma,
63187). After 30 min of incubation at 4C, lysates were clarified by centrifuga-
tion (1min at 30,000 rpm) and allowed to incubate for 16 hr at 4Cwith rotation.
Unreacted PEG-maleimide was quenched by 3 hr of incubation with 10 mM
DTT. The extracts were diluted with 400 ml of PBS, 1X PIC and processed
for immunoprecipitation.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, one
table, five figures, and Supplemental References and can be found with this
article online at http://www.cell.com/supplemental/S0092-8674(08)01562-6.
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